Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q3)Oct 4, 2025 | (Q2)Jun 14, 2025 | (Q1)Mar 22, 2025 | (FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Oct 5, 2024 | (Q2)Jun 15, 2024 | (Q1)Mar 23, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 4.62%19.55B | 5.19%14.82B | 4.00%14.29B | 2.47%61.61B | 2.70%15.1B | 1.51%18.69B | 1.49%14.09B | 4.58%13.74B | 5.39%60.12B | 3.95%14.7B |
| Operating revenue | 4.62%19.55B | 5.19%14.82B | 4.00%14.29B | 2.47%61.61B | 2.70%15.1B | 1.51%18.69B | 1.49%14.09B | 4.58%13.74B | 5.39%60.12B | 3.95%14.7B |
| Cost of revenue | 4.17%13.19B | 5.33%9.82B | 4.21%9.52B | 1.94%41.3B | 2.96%10.17B | 1.05%12.67B | 0.15%9.33B | 3.95%9.14B | 5.15%40.51B | 3.05%9.88B |
| Gross profit | 5.56%6.36B | 4.93%5B | 3.59%4.77B | 3.57%20.31B | 2.18%4.93B | 2.50%6.02B | 4.22%4.77B | 5.87%4.6B | 5.89%19.61B | 5.84%4.82B |
| Operating expense | 7.16%4.72B | -10.33%3.56B | 1.63%3.69B | 4.51%15.94B | 5.05%3.93B | -5.17%4.4B | 14.31%3.97B | 7.11%3.63B | 9.17%15.25B | 13.80%3.75B |
| Selling and administrative expenses | 7.16%4.72B | -10.33%3.56B | 1.63%3.69B | 4.51%15.94B | 5.05%3.93B | -5.17%4.4B | 14.31%3.97B | 7.11%3.63B | 9.17%15.25B | 13.80%3.75B |
| Operating profit | 1.24%1.64B | 81.13%1.44B | 10.92%1.08B | 0.30%4.38B | -7.81%992M | 31.44%1.62B | -27.66%795M | 1.46%971M | -4.17%4.36B | -14.87%1.08B |
| Net non-operating interest income (expenses) | 52.23%-418M | -16,433.33%-490M | -106.51%-444M | -9.34%-972M | 117.42%115M | -929.41%-875M | 104.11%3M | 18.25%-215M | 2.63%-889M | 27.95%-660M |
| Non-operating interest income | -55.56%16M | -50.00%12M | -4.55%21M | 5.49%96M | -36.36%14M | 33.33%36M | 26.32%24M | -4.35%22M | 28.17%91M | 0.00%22M |
| Non-operating interest expense | 7.00%367M | 6.44%314M | 2.03%302M | 1.73%1.23B | -0.67%298M | 3.63%343M | 0.34%295M | 3.50%296M | 11.92%1.21B | 8.70%300M |
| Total other finance cost | -88.20%67M | 168.61%188M | 376.27%163M | 29.00%-164M | -204.45%-399M | 359.36%568M | -35.64%-274M | ---59M | -135.71%-231M | -42.30%382M |
| Other net income (expenses) | -69.27%59M | |||||||||
| Gain on sale of security | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -69.27%59M | ---- | ---- |
| Income before tax | 64.20%1.22B | 19.05%950M | -16.27%633M | -2.01%3.4B | 166.11%1.11B | -35.17%743M | -22.22%798M | -14.67%756M | -4.56%3.47B | 19.54%416M |
| Income tax | 11.55%338M | 130.53%302M | 7.20%283M | 6.95%908M | 24.26%210M | 50.00%303M | -46.31%131M | 12.82%264M | 2.17%849M | -20.66%169M |
| Earnings from equity interest net of tax | ||||||||||
| Net income | 100.45%882M | -2.85%648M | -28.86%350M | -4.91%2.5B | 263.16%897M | -53.39%440M | -14.71%667M | -24.54%492M | -6.35%2.63B | 82.96%247M |
| Net income continuous operations | 100.45%882M | -2.85%648M | -28.86%350M | -4.91%2.5B | 263.16%897M | -53.39%440M | -14.71%667M | -24.54%492M | -6.55%2.63B | 82.96%247M |
| Noncontrolling interests | -4.87%391M | 47.86%380M | 4.47%257M | 4.79%1.14B | -18.91%223M | 28.44%411M | -6.20%257M | 13.89%246M | 9.93%1.09B | 15.06%275M |
| Net income attributable to the company | 1,593.10%491M | -34.63%268M | -62.20%93M | -11.75%1.36B | 2,507.14%674M | -95.35%29M | -19.29%410M | -43.58%246M | -15.20%1.54B | 73.08%-28M |
| Preferred stock dividends | 0.00%14M | 0.00%10M | 0.00%10M | 0.00%44M | 0.00%10M | 0.00%14M | 0.00%10M | 0.00%10M | 0.00%44M | 0.00%10M |
| Other under preferred stock dividend | ||||||||||
| Net income attributable to common stockholders | 3,080.00%477M | -35.50%258M | -64.83%83M | -12.10%1.32B | 1,847.37%664M | -97.54%15M | -19.68%400M | -44.60%236M | -15.58%1.5B | 68.33%-38M |
| Diluted earnings per share | 3,000.00%1.24 | -33.55%0.6667 | -63.64%0.2133 | -8.55%3.3167 | 1,921.44%1.7 | -97.31%0.04 | -16.16%1.0033 | -42.11%0.5867 | -11.47%3.6267 | 60.56%-0.0933 |
| Basic earnings per share | 4,000.00%1.23 | -34.01%0.6533 | -64.16%0.2067 | -8.84%3.2667 | 1,783.33%1.6833 | -97.96%0.03 | -16.34%0.99 | -42.52%0.5767 | -11.60%3.5833 | 58.90%-0.1 |
| Dividend per share | 9.00%0.2979 | 9.00%0.2979 | 15.01%0.2733 | 13.36%1.0577 | 15.01%0.2733 | 15.01%0.2733 | 15.01%0.2733 | 8.03%0.2377 | 8.49%0.933 | 8.03%0.2377 |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.